Prelude Therapeutics shares are trading lower after the company announced pricing of a public offering.
Portfolio Pulse from Benzinga Newsdesk
Prelude Therapeutics announced the pricing of a public offering, causing its shares to trade lower.
May 18, 2023 | 12:57 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Prelude Therapeutics' stock price is trading lower due to the announcement of a public offering pricing.
The announcement of the public offering pricing has led to a decrease in the stock price of Prelude Therapeutics. Investors may be concerned about the dilution of shares or the pricing of the offering, causing the stock price to trade lower in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100